Mission accepted.
In our media library you will find publications, videos and picture material about the CARL Technology, which document the current state of development and the performance of our products.
© Resuscitec 2021. The image and media material is protected by copyright. Use exclusively for editorial purposes and reporting, provided the author is acknowledged. The material may not be modified.
CARL. pushes back the boundaries of resuscitation therapy
Innovation in emergency medicine
A recent article on the “resuscitation concept CARL” has been published on Gesundheitsindustrie-BW.de.
Editor-in-Chief: Dr. Ruth Menßen-Franz, BIOPRO Baden-Württemberg GmbH
New press release
Change in management and sales management:
Dr. Thomas Kraft and Dr. Patrick Rauh leave Resuscitec GmbH
Treatment of Refractory Cardiac Arrest by Controlled Reperfusion of the Whole Body: A Multicenter, Prospective Observational Study
Study published by the CARL-Centers Freiburg, Rotterdam, Linz, Regensburg, Düsseldorf, HH St. Georg and Bad Oeynhausen
CARL. in the Apotheken Umschau
In the February issue Apotheken Umschau, the CARL Technology and its mode of operation are presented under the title “Grenzen verschieben” by means of a detailed graphic.
Current publication on the application of the CARL. Technology at the Regensburg University Hospital
An article was published in the journal Perfusion in November 2022 presenting data from the first ten patients suffering from an out-of-hospital cardiovascular arrest who were treated by using the CARL Technology in Regensburg.
Recent Nature publication: Cellular recovery after prolonged warm ischaemia of the whole body
Presentation of the CARL. Technology during the visit of the Minister of the Interior Thomas Strobl at the Medical Center – University of Freiburg
Interior Minister Thomas Strobl has visited the Medical Center – University of Freiburg where the CARL Technology was presented.
CARL. -induced changes of the serum proteome
A recent publication in the Journal of Translational Medicine in May 2022 describes significant changes in serum protein composition after resuscitation using controlled extracorporeal circulation in pigs.
Current publication on the benefit of the CARL. Therapy
The Journal of Clinical Medicine recently published an article describing the benefits of adapted perfusion and defibrillation strategies in the setting of CARL Therapy.
Letter to the editor: Important factors regarding the analysis of extracorporeal blood flow in extracorporeal cardiopulmonary resuscitation.
INVITED EXPERT OPINION IN THE JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (JTCVS)
An Invited Expert Opinion has been published in the Journal of Thoracic and Cardiovascular Surgery (JTCVS) on the use of cardiac surgical techniques to improve outcomes of cardiopulmonary resuscitation after cardiovascular arrest.
For more information on CARL Therapy, please visit: Therapy (resuscitec.de)
Thanks to CARL. – Larger time frame for successful resuscitation in cardiac arrest (text: German language)
The CARL Therapy developed by researchers of
The Medical Center – University of Freiburg and the mobile CARL Technology of Resuscitec GmbH provide a larger time window for the treatment of patients requiring resuscitation. An article published in “Ärztezeitung” in August, 2021 describes the therapeutic factors that are crucial for successful resuscitation even after prolonged cardiac arrest.
‘Originally it was not planned to treat Covid patients at all’ (text: German language)
Interview with Prof. Dr.-Ing. Christoph Benk and Jörg Ronde, Managing Directors of Resuscitec GmbH in the VentureCapital Magazin
New method of resuscitation: unharmed despite one-and-a-half hours of cardiac arrest (text: German language)
Just ten percent of those affected survive a cardiac arrest that happens outside a hospital – and only some of them without sequelae. A new method might change this. The ‘Neue Züricher Zeitung’ has published an article about CARL.
Sudden cardiac arrest – Doc Fischer talks about CARL. in SWR-TV
It can happen to anyone at any time. Sudden cardiac arrest. The SWR-health programme ‘Doc Fischer’ explains the causes of sudden cardiac arrest, patient prevention possibilities and how the new second-line therapy CARL might improve survival rates further, both in-hospital and out-of-hospital.
Image: SWR
To the video >(minute 12:50)
Thanks to CARL.
In the following video, SWR reports on the success story of the therapy for CARL patient P. Kunzelmann.
Imagefilm Resuscitec GmbH
The CARL Technology and its application possibilities
Another young life was saved – thanks to CARL.
A 36-year-old woman suffered a prolonged cardiac arrest lasting over one and a half hours. Only the use of CARL. enabled a successful resuscitation. The TV station SWR tells her story with CARL. in the following video (minute 13:12).
CARL. Video
CARL product video
Abstract of the publication „Brain vulnerability and viability after ischemia” from the journal Nature Review Neuroscience
Professor Dr. Dr. h. c. Friedhelm Beyersdorf about the scientific basis of the CARL Therapy
CARL INV Teaser
CARL System
CARL Controller frontal view
CARL Controller side view
CARL System with rack
